Skip to main content
. 2018 Jun 22;10(7):212. doi: 10.3390/cancers10070212

Figure 4.

Figure 4

Combination of molecular targeted therapy and immunotherapy. Cancer cells harbor many mutations, typically single driver mutation and many passenger mutations in lung cancer. Driver and passenger mutations can become the therapeutic target for molecular targeted therapy and immunotherapy, respectively.